Krishna Institute of Medical Sciences Limited has announced a scheduled analyst and institutional investor meeting with Aberdeen, set to take place on March 18, 2026. The disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details

The upcoming investor engagement has been structured as a virtual meeting to facilitate broader participation and accessibility.

Regulatory Compliance

The company has made this announcement pursuant to SEBI's disclosure requirements for listed entities. Krishna Institute of Medical Sciences has specifically noted that no unpublished price sensitive information will be shared during the scheduled meeting, ensuring compliance with insider trading regulations.

Schedule Flexibility

The healthcare services provider has indicated that the meeting schedule remains subject to change due to any exigencies that may arise. This standard disclaimer provides flexibility while maintaining transparency with stakeholders about potential scheduling adjustments.

The disclosure was signed by Nagajayanthi J.R, who serves as the Company Secretary and Compliance Officer for Krishna Institute of Medical Sciences Limited. The formal communication was digitally signed and submitted to both the Bombay Stock Exchange and National Stock Exchange on March 14, 2026.

Krishna Institute of Medical Sciences Limited has successfully concluded its board meeting held on March 11, 2026, with the approval of a significant fund raising proposal worth ₹1,500 crores. The company had earlier informed stock exchanges about the meeting scheduled to deliberate on fund raising options, filing the intimation on March 6, 2026, in compliance with SEBI LODR Regulations.

Board Meeting Outcomes

The board meeting, convened under Regulation 29(1)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, has resulted in concrete decisions regarding the company's capital raising strategy. The meeting commenced at 12:00 Noon and concluded at 1:20 PM, with the board approving the issuance of equity shares through Qualified Institutions Placement (QIP) as the preferred methodology.

Fund Raising Methodology

The company has finalized its approach to raise funds for an aggregate amount of up to ₹1,500 crores through equity share issuance via QIP mechanism and/or any other permissible mode or combination thereof. The issuance will be conducted in one or more tranches, in accordance with the applicable provisions of the Companies Act, 2013 and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018.

Postal Ballot Approval

In addition to approving the fund raising proposal, the board has also approved the conduct of a postal ballot to seek shareholders' consent for the proposed equity issuance. The board has approved the Postal Ballot Notice, which will be circulated to members in due course, in accordance with applicable laws. This step ensures proper governance and member participation in the capital raising decision.

Committee Authorization

The board has authorized the Finance & Investment Committee to decide the terms and conditions of the proposed fund raise. The final terms and conditions of the QIP will be determined based on market conditions and regulatory requirements at the time of issuance, subject to receipt of necessary approvals including shareholders' approval and other regulatory and statutory approvals as may be required.